Scientists at Columbia University have successfully performed precise gene editing on early human embryos using a revolutionary method known as base editing, marking a significant advancement that could pave the way for correcting disease-causing mutations before birth.
The achievement comes amid ongoing ethical debates about the possibility of genetically modifying human embryos. While the technology offers potential to repair harmful genetic mutations, it also raises concerns about the potential for selecting non-medical traits—a practice some ethicists warn could veer into eugenics.
“As a scientist, you can provide the data for discussion, but then essentially there you stop and let others take over,” said Dr. Dieter Egli, the Columbia geneticist who led the research.
Using base editing—a more precise technique than traditional CRISPR—researchers were able to make targeted changes to DNA sequences without the extensive damage typically associated with earlier gene-editing methods. Dr. Egli emphasized that while the research shows promise, many questions about safety remain unresolved.
“We’re not saying this is going to be used tomorrow in the clinics,” he cautioned.
The research team published their findings online while awaiting peer review for journal publication. Their work builds upon earlier studies that highlighted both the potential and peril of embryo editing.
A 2018 incident underscored the risks: Chinese scientist He Jiankui claimed to have created the first gene-edited babies using CRISPR, later receiving a three-year prison sentence. Despite claiming success, independent evaluation of those children has never occurred.
Base editing, developed in 2016 by Harvard geneticist David Liu, works by making precise single-strand nicks in DNA rather than cutting both strands, allowing cells to repair mutations more accurately. This approach has shown particular promise in recent therapeutic applications, including a 2023 case where a baby was born healthy after receiving base-editing treatment for a lethal genetic disorder.
In the Columbia experiments, researchers targeted two specific genes: PCSK9, associated with elevated cholesterol and heart disease risk, and HBG, involved in fetal hemoglobin production. When delivered to fertilized eggs and two-cell embryos donated by parents, the base editors showed remarkable precision without the chromosomal damage seen in CRISPR applications.
The researchers successfully modified both genes simultaneously in some embryos, though the technique is not yet flawless. Occasionally, base editors failed to reach their targets, resulting in genetic mosaics—embryos with mixed populations of edited and unedited cells. Such mosaics pose potential health risks if development proceeds.
Despite these limitations, some experts remain optimistic. Dr. Paula Amato, a fertility specialist at Oregon Health & Science University, described the method as “promising” and emphasized the importance of reviewing the final published results.
1. I need to output ONLY the block at the beginning, followed immediately by the rewritten content
2. I must NOT alter, delete, or skip any HTML media elements (img tags, video iframes, shorts, Twitter/X blockquote embed codes)
3. I need to rewrite the headline to be unique and professional
4. I need to rewrite the body into natural, high-quality professional English
5. I should clean the text by removing promotional lines, “SEE ALSO” links, and footer junk (though I don’t see obvious ones in this content)
Looking at the original HTML:
– There are two
– The original headline is “In a First, Scientists Precisely Edit Human Embryo Genes”
– The body has CSS classes I should strip (like css-ac37hb, etc.)
– There are some assessment/date/footer elements I should remove
Let me rewrite this properly:
Also Read
- The EmotionalBurden of Caring for a Parent Who Once Abused You
- Pfizer’s Penicillin Crisis: Delayed Treatment for Pregnant Syphilis Patient
- Paul Markovich Outlines Four Strategic Reforms to Curb Rising U.S. Healthcare Costs
- Patients with hypermobility disorders in UK face diagnosis delays of up to 21 years

